APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Drug Consulting Service

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Drug Consulting Service Industry Growth and Trends Forecast to 2032

Report ID 17412308018 January 2026111 pages

Choose your research edition.

Industry ResearchDrug Consulting Service Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Consulting Service Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Drug Consulting Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Consulting Service Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Consulting Service Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

According to APO Research, the global Drug Consulting Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Drug Consulting Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Drug Consulting Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drug Consulting Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Drug Consulting Service market include Livingston International Inc., Alacrita Holdings Limited, Victory Packaging, Intertek Group plc, EAS CONSULTING GROUP, Pharmaceutical Development Group, Inc., EAG Laboratories, Aphena Pharma Solutions and Labcorp Drug Development, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Drug Consulting Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Drug Consulting Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Drug Consulting Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Drug Consulting Service.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Drug Consulting Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Drug Consulting Service Market by Company

Livingston International Inc.

Alacrita Holdings Limited

Victory Packaging

Intertek Group plc

EAS CONSULTING GROUP

Pharmaceutical Development Group, Inc.

EAG Laboratories

Aphena Pharma Solutions

Labcorp Drug Development

Engineering Systems Inc.

Parexel

SGS North America Inc.

ICON plc

Decision Resources Group

Premier Consulting

Copyright Owensboro Health.

Orphan Drug Consulting

Societal CDMO

Drug Consulting Service Segment by Type

R&D Consulting

Test Consulting

Design Consulting

Analysis Consulting

Other

Drug Consulting Service Segment by Application

Nutrition

Cosmetic

Dentistry

Pharmaceutical

Other

Drug Consulting Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Consulting Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Consulting Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Consulting Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Drug Consulting Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Drug Consulting Service Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Drug Consulting Service Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Drug Consulting Service Market Share by Region (2021-2026) Table 4. Global Drug Consulting Service Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Drug Consulting Service Market Share by Region (2027-2032) Table 6. Global Drug Consulting Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Drug Consulting Service Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Drug Consulting Service Market Size Share by Type (2021-2026) Table 9. Global Drug Consulting Service Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Drug Consulting Service Market Size Share Forecasted by Type (2027-2032) Table 11. North America Drug Consulting Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Drug Consulting Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Drug Consulting Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Drug Consulting Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Drug Consulting Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Drug Consulting Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Drug Consulting Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Drug Consulting Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Drug Consulting Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Drug Consulting Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Drug Consulting Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Drug Consulting Service Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Drug Consulting Service Market Size Share by Application (2021-2026) Table 24. Global Drug Consulting Service Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Drug Consulting Service Market Size Share Forecasted by Application (2027-2032) Table 26. North America Drug Consulting Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Drug Consulting Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Drug Consulting Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Drug Consulting Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Drug Consulting Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Drug Consulting Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Drug Consulting Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Drug Consulting Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Drug Consulting Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Drug Consulting Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Drug Consulting Service Industry Trends Table 37. Drug Consulting Service Industry Drivers Table 38. Drug Consulting Service Industry Opportunities and Challenges Table 39. Drug Consulting Service Industry Restraints Table 40. Global Drug Consulting Service Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Drug Consulting Service Revenue Market Share by Company (2021-2026) Table 42. Global Drug Consulting Service Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Drug Consulting Service Key Company Headquarters & Area Served Table 44. Global Drug Consulting Service Company, Product Type & Application Table 45. Global Drug Consulting Service Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Drug Consulting Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Livingston International Inc. Company Information Table 49. Livingston International Inc. Business Overview Table 50. Livingston International Inc. Drug Consulting Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Livingston International Inc. Drug Consulting Service Product Portfolio Table 52. Livingston International Inc. Recent Development Table 53. Alacrita Holdings Limited Company Information Table 54. Alacrita Holdings Limited Business Overview Table 55. Alacrita Holdings Limited Drug Consulting Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Alacrita Holdings Limited Drug Consulting Service Product Portfolio Table 57. Alacrita Holdings Limited Recent Development Table 58. Victory Packaging Company Information Table 59. Victory Packaging Business Overview Table 60. Victory Packaging Drug Consulting Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Victory Packaging Drug Consulting Service Product Portfolio Table 62. Victory Packaging Recent Development Table 63. Intertek Group plc Company Information Table 64. Intertek Group plc Business Overview Table 65. Intertek Group plc Drug Consulting Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Intertek Group plc Drug Consulting Service Product Portfolio Table 67. Intertek Group plc Recent Development Table 68. EAS CONSULTING GROUP Company Information Table 69. EAS CONSULTING GROUP Business Overview Table 70. EAS CONSULTING GROUP Drug Consulting Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. EAS CONSULTING GROUP Drug Consulting Service Product Portfolio Table 72. EAS CONSULTING GROUP Recent Development Table 73. Pharmaceutical Development Group, Inc. Company Information Table 74. Pharmaceutical Development Group, Inc. Business Overview Table 75. Pharmaceutical Development Group, Inc. Drug Consulting Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Pharmaceutical Development Group, Inc. Drug Consulting Service Product Portfolio Table 77. Pharmaceutical Development Group, Inc. Recent Development Table 78. EAG Laboratories Company Information Table 79. EAG Laboratories Business Overview Table 80. EAG Laboratories Drug Consulting Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. EAG Laboratories Drug Consulting Service Product Portfolio Table 82. EAG Laboratories Recent Development Table 83. Aphena Pharma Solutions Company Information Table 84. Aphena Pharma Solutions Business Overview Table 85. Aphena Pharma Solutions Drug Consulting Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Aphena Pharma Solutions Drug Consulting Service Product Portfolio Table 87. Aphena Pharma Solutions Recent Development Table 88. Labcorp Drug Development Company Information Table 89. Labcorp Drug Development Business Overview Table 90. Labcorp Drug Development Drug Consulting Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Labcorp Drug Development Drug Consulting Service Product Portfolio Table 92. Labcorp Drug Development Recent Development Table 93. Engineering Systems Inc. Company Information Table 94. Engineering Systems Inc. Business Overview Table 95. Engineering Systems Inc. Drug Consulting Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Engineering Systems Inc. Drug Consulting Service Product Portfolio Table 97. Engineering Systems Inc. Recent Development Table 98. Parexel Company Information Table 99. Parexel Business Overview Table 100. Parexel Drug Consulting Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Parexel Drug Consulting Service Product Portfolio Table 102. Parexel Recent Development Table 103. SGS North America Inc. Company Information Table 104. SGS North America Inc. Business Overview Table 105. SGS North America Inc. Drug Consulting Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. SGS North America Inc. Drug Consulting Service Product Portfolio Table 107. SGS North America Inc. Recent Development Table 108. ICON plc Company Information Table 109. ICON plc Business Overview Table 110. ICON plc Drug Consulting Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. ICON plc Drug Consulting Service Product Portfolio Table 112. ICON plc Recent Development Table 113. Decision Resources Group Company Information Table 114. Decision Resources Group Business Overview Table 115. Decision Resources Group Drug Consulting Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Decision Resources Group Drug Consulting Service Product Portfolio Table 117. Decision Resources Group Recent Development Table 118. Premier Consulting Company Information Table 119. Premier Consulting Business Overview Table 120. Premier Consulting Drug Consulting Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Premier Consulting Drug Consulting Service Product Portfolio Table 122. Premier Consulting Recent Development Table 123. Copyright Owensboro Health. Company Information Table 124. Copyright Owensboro Health. Business Overview Table 125. Copyright Owensboro Health. Drug Consulting Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Copyright Owensboro Health. Drug Consulting Service Product Portfolio Table 127. Copyright Owensboro Health. Recent Development Table 128. Orphan Drug Consulting Company Information Table 129. Orphan Drug Consulting Business Overview Table 130. Orphan Drug Consulting Drug Consulting Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Orphan Drug Consulting Drug Consulting Service Product Portfolio Table 132. Orphan Drug Consulting Recent Development Table 133. Societal CDMO Company Information Table 134. Societal CDMO Business Overview Table 135. Societal CDMO Drug Consulting Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Societal CDMO Drug Consulting Service Product Portfolio Table 137. Societal CDMO Recent Development Table 138. North America Drug Consulting Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Drug Consulting Service Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Drug Consulting Service Market Share by Country (2021-2026) Table 141. North America Drug Consulting Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Drug Consulting Service Market Share Forecast by Country (2027-2032) Table 143. Europe Drug Consulting Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Drug Consulting Service Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Drug Consulting Service Market Share by Country (2021-2026) Table 146. Europe Drug Consulting Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Drug Consulting Service Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Drug Consulting Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Drug Consulting Service Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Drug Consulting Service Market Share by Country (2021-2026) Table 151. Asia-Pacific Drug Consulting Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Drug Consulting Service Market Share Forecast by Country (2027-2032) Table 153. Latin America Drug Consulting Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Drug Consulting Service Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Drug Consulting Service Market Share by Country (2021-2026) Table 156. Latin America Drug Consulting Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Drug Consulting Service Market Share Forecast by Country (2027-2032) Table 158. Middle East & Africa Drug Consulting Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East & Africa Drug Consulting Service Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East & Africa Drug Consulting Service Market Share by Country (2021-2026) Table 161. Middle East & Africa Drug Consulting Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East & Africa Drug Consulting Service Market Share Forecast by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Drug Consulting Service Product Image Figure 3. Global Drug Consulting Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Drug Consulting Service Market Size (2021-2032) & (US$ Million) Figure 5. Global Drug Consulting Service Market Share by Region: 2025 VS 2032 Figure 6. Global Drug Consulting Service Market Share by Region (2021-2032) Figure 7. North America Drug Consulting Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Drug Consulting Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Drug Consulting Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Drug Consulting Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Drug Consulting Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. R&D Consulting Image Figure 13. Global R&D Consulting Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Test Consulting Image Figure 15. Global Test Consulting Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Design Consulting Image Figure 17. Global Design Consulting Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Analysis Consulting Image Figure 19. Global Analysis Consulting Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Other Image Figure 21. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Drug Consulting Service Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Drug Consulting Service Market Share by Type 2025 VS 2032 Figure 24. North America Drug Consulting Service Market Size Share by Type (2021-2032) Figure 25. Europe Drug Consulting Service Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Drug Consulting Service Market Size Share by Type (2021-2032) Figure 27. Latin America Drug Consulting Service Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Drug Consulting Service Market Size Share by Type (2021-2032) Figure 29. Nutrition Image Figure 30. Global Nutrition Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Cosmetic Image Figure 32. Global Cosmetic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Dentistry Image Figure 34. Global Dentistry Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Pharmaceutical Image Figure 36. Global Pharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Other Image Figure 38. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Global Drug Consulting Service Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Drug Consulting Service Market Share by Application 2025 VS 2032 Figure 41. North America Drug Consulting Service Market Size Share by Application (2021-2032) Figure 42. Europe Drug Consulting Service Market Size Share by Application (2021-2032) Figure 43. Asia-Pacific Drug Consulting Service Market Size Share by Application (2021-2032) Figure 44. Latin America Drug Consulting Service Market Size Share by Application (2021-2032) Figure 45. Middle East and Africa Drug Consulting Service Market Size Share by Application (2021-2032) Figure 46. Global Top 5 and 10 Drug Consulting Service Players Market Share by Revenue in 2025 Figure 47. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 48. North America Drug Consulting Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. North America Drug Consulting Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. North America Drug Consulting Service Market Share by Country (2021-2032) Figure 51. Europe Drug Consulting Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Drug Consulting Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Drug Consulting Service Market Share by Country (2021-2032) Figure 54. Asia-Pacific Drug Consulting Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Asia-Pacific Drug Consulting Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Asia-Pacific Drug Consulting Service Market Share by Country (2021-2032) Figure 57. Latin America Drug Consulting Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Drug Consulting Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Drug Consulting Service Market Share by Country (2021-2032) Figure 60. Middle East & Africa Drug Consulting Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Middle East & Africa Drug Consulting Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 62. Middle East & Africa Drug Consulting Service Market Share by Country (2021-2032) Figure 63. Years Considered Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • R&D Consulting
  • Test Consulting
  • Design Consulting
  • Analysis Consulting
  • Other
Applications
  • Nutrition
  • Cosmetic
  • Dentistry
  • Pharmaceutical
  • Other
Companies covered
  • Livingston International Inc.
  • Alacrita Holdings Limited
  • Victory Packaging
  • Intertek Group plc
  • EAS CONSULTING GROUP
  • Pharmaceutical Development Group, Inc.
  • EAG Laboratories
  • Aphena Pharma Solutions
  • Labcorp Drug Development
  • Engineering Systems Inc.
  • Parexel
  • SGS North America Inc.
  • ICON plc
  • Decision Resources Group
  • Premier Consulting
  • Copyright Owensboro Health.
  • Orphan Drug Consulting
  • Societal CDMO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Drug Consulting Service Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Drug Consulting Service Market Size by Region (2021-2032)
  5. 1.4.1 Global Drug Consulting Service Market Size by Region (2021-2026)
  6. 1.4.2 Global Drug Consulting Service Market Size by Region (2027-2032)
  7. 1.5 Key Regions Drug Consulting Service Market Size (2021-2032)
  8. 1.5.1 North America Drug Consulting Service Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Drug Consulting Service Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Drug Consulting Service Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Drug Consulting Service Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Drug Consulting Service Market Size Growth Rate (2021-2032)
2 Drug Consulting Service Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 R&D Consulting
  3. 2.1.2 Test Consulting
  4. 2.1.3 Design Consulting
  5. 2.1.4 Analysis Consulting
  6. 2.1.5 Other
  7. 2.2 Global Drug Consulting Service Market Size by Type
  8. 2.2.1 Global Drug Consulting Service Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Drug Consulting Service Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Drug Consulting Service Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Drug Consulting Service Market Size by Regions
  12. 2.3.1 North America Drug Consulting Service Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Drug Consulting Service Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Drug Consulting Service Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Drug Consulting Service Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Drug Consulting Service Market Size Breakdown by Type (2021-2026)
3 Drug Consulting Service Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Nutrition
  3. 3.1.2 Cosmetic
  4. 3.1.3 Dentistry
  5. 3.1.4 Pharmaceutical
  6. 3.1.5 Other
  7. 3.2 Global Drug Consulting Service Market Size by Application
  8. 3.2.1 Global Drug Consulting Service Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global Drug Consulting Service Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global Drug Consulting Service Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global Drug Consulting Service Market Size by Regions
  12. 3.3.1 North America Drug Consulting Service Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe Drug Consulting Service Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific Drug Consulting Service Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America Drug Consulting Service Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa Drug Consulting Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Drug Consulting Service Industry Trends
  2. 4.2 Drug Consulting Service Industry Drivers
  3. 4.3 Drug Consulting Service Industry Opportunities and Challenges
  4. 4.4 Drug Consulting Service Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Drug Consulting Service Revenue (2021-2026)
  2. 5.2 Global Drug Consulting Service Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Drug Consulting Service Key Company Headquarters & Area Served
  4. 5.4 Global Drug Consulting Service Company, Product Type & Application
  5. 5.5 Global Drug Consulting Service Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Drug Consulting Service Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Drug Consulting Service Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Drug Consulting Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Livingston International Inc.
  2. 6.1.1 Livingston International Inc. Company Information
  3. 6.1.2 Livingston International Inc. Business Overview
  4. 6.1.3 Livingston International Inc. Drug Consulting Service Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Livingston International Inc. Drug Consulting Service Product Portfolio
  6. 6.1.5 Livingston International Inc. Recent Developments
  7. 6.2 Alacrita Holdings Limited
  8. 6.2.1 Alacrita Holdings Limited Company Information
  9. 6.2.2 Alacrita Holdings Limited Business Overview
  10. 6.2.3 Alacrita Holdings Limited Drug Consulting Service Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Alacrita Holdings Limited Drug Consulting Service Product Portfolio
  12. 6.2.5 Alacrita Holdings Limited Recent Developments
  13. 6.3 Victory Packaging
  14. 6.3.1 Victory Packaging Company Information
  15. 6.3.2 Victory Packaging Business Overview
  16. 6.3.3 Victory Packaging Drug Consulting Service Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Victory Packaging Drug Consulting Service Product Portfolio
  18. 6.3.5 Victory Packaging Recent Developments
  19. 6.4 Intertek Group plc
  20. 6.4.1 Intertek Group plc Company Information
  21. 6.4.2 Intertek Group plc Business Overview
  22. 6.4.3 Intertek Group plc Drug Consulting Service Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Intertek Group plc Drug Consulting Service Product Portfolio
  24. 6.4.5 Intertek Group plc Recent Developments
  25. 6.5 EAS CONSULTING GROUP
  26. 6.5.1 EAS CONSULTING GROUP Company Information
  27. 6.5.2 EAS CONSULTING GROUP Business Overview
  28. 6.5.3 EAS CONSULTING GROUP Drug Consulting Service Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 EAS CONSULTING GROUP Drug Consulting Service Product Portfolio
  30. 6.5.5 EAS CONSULTING GROUP Recent Developments
  31. 6.6 Pharmaceutical Development Group, Inc.
  32. 6.6.1 Pharmaceutical Development Group, Inc. Company Information
  33. 6.6.2 Pharmaceutical Development Group, Inc. Business Overview
  34. 6.6.3 Pharmaceutical Development Group, Inc. Drug Consulting Service Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Pharmaceutical Development Group, Inc. Drug Consulting Service Product Portfolio
  36. 6.6.5 Pharmaceutical Development Group, Inc. Recent Developments
  37. 6.7 EAG Laboratories
  38. 6.7.1 EAG Laboratories Company Information
  39. 6.7.2 EAG Laboratories Business Overview
  40. 6.7.3 EAG Laboratories Drug Consulting Service Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 EAG Laboratories Drug Consulting Service Product Portfolio
  42. 6.7.5 EAG Laboratories Recent Developments
  43. 6.8 Aphena Pharma Solutions
  44. 6.8.1 Aphena Pharma Solutions Company Information
  45. 6.8.2 Aphena Pharma Solutions Business Overview
  46. 6.8.3 Aphena Pharma Solutions Drug Consulting Service Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Aphena Pharma Solutions Drug Consulting Service Product Portfolio
  48. 6.8.5 Aphena Pharma Solutions Recent Developments
  49. 6.9 Labcorp Drug Development
  50. 6.9.1 Labcorp Drug Development Company Information
  51. 6.9.2 Labcorp Drug Development Business Overview
  52. 6.9.3 Labcorp Drug Development Drug Consulting Service Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Labcorp Drug Development Drug Consulting Service Product Portfolio
  54. 6.9.5 Labcorp Drug Development Recent Developments
  55. 6.10 Engineering Systems Inc.
  56. 6.10.1 Engineering Systems Inc. Company Information
  57. 6.10.2 Engineering Systems Inc. Business Overview
  58. 6.10.3 Engineering Systems Inc. Drug Consulting Service Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Engineering Systems Inc. Drug Consulting Service Product Portfolio
  60. 6.10.5 Engineering Systems Inc. Recent Developments
  61. 6.11 Parexel
  62. 6.11.1 Parexel Company Information
  63. 6.11.2 Parexel Business Overview
  64. 6.11.3 Parexel Drug Consulting Service Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Parexel Drug Consulting Service Product Portfolio
  66. 6.11.5 Parexel Recent Developments
  67. 6.12 SGS North America Inc.
  68. 6.12.1 SGS North America Inc. Company Information
  69. 6.12.2 SGS North America Inc. Business Overview
  70. 6.12.3 SGS North America Inc. Drug Consulting Service Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 SGS North America Inc. Drug Consulting Service Product Portfolio
  72. 6.12.5 SGS North America Inc. Recent Developments
  73. 6.13 ICON plc
  74. 6.13.1 ICON plc Company Information
  75. 6.13.2 ICON plc Business Overview
  76. 6.13.3 ICON plc Drug Consulting Service Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 ICON plc Drug Consulting Service Product Portfolio
  78. 6.13.5 ICON plc Recent Developments
  79. 6.14 Decision Resources Group
  80. 6.14.1 Decision Resources Group Company Information
  81. 6.14.2 Decision Resources Group Business Overview
  82. 6.14.3 Decision Resources Group Drug Consulting Service Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Decision Resources Group Drug Consulting Service Product Portfolio
  84. 6.14.5 Decision Resources Group Recent Developments
  85. 6.15 Premier Consulting
  86. 6.15.1 Premier Consulting Company Information
  87. 6.15.2 Premier Consulting Business Overview
  88. 6.15.3 Premier Consulting Drug Consulting Service Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Premier Consulting Drug Consulting Service Product Portfolio
  90. 6.15.5 Premier Consulting Recent Developments
  91. 6.16 Copyright Owensboro Health.
  92. 6.16.1 Copyright Owensboro Health. Company Information
  93. 6.16.2 Copyright Owensboro Health. Business Overview
  94. 6.16.3 Copyright Owensboro Health. Drug Consulting Service Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Copyright Owensboro Health. Drug Consulting Service Product Portfolio
  96. 6.16.5 Copyright Owensboro Health. Recent Developments
  97. 6.17 Orphan Drug Consulting
  98. 6.17.1 Orphan Drug Consulting Company Information
  99. 6.17.2 Orphan Drug Consulting Business Overview
  100. 6.17.3 Orphan Drug Consulting Drug Consulting Service Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Orphan Drug Consulting Drug Consulting Service Product Portfolio
  102. 6.17.5 Orphan Drug Consulting Recent Developments
  103. 6.18 Societal CDMO
  104. 6.18.1 Societal CDMO Company Information
  105. 6.18.2 Societal CDMO Business Overview
  106. 6.18.3 Societal CDMO Drug Consulting Service Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Societal CDMO Drug Consulting Service Product Portfolio
  108. 6.18.5 Societal CDMO Recent Developments
7 North America
  1. 7.1 North America Drug Consulting Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Drug Consulting Service Market Size by Country (2021-2026)
  3. 7.3 North America Drug Consulting Service Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Drug Consulting Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Drug Consulting Service Market Size by Country (2021-2026)
  3. 8.3 Europe Drug Consulting Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Drug Consulting Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Drug Consulting Service Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Drug Consulting Service Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Drug Consulting Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Drug Consulting Service Market Size by Country (2021-2026)
  3. 10.3 South America Drug Consulting Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Drug Consulting Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Drug Consulting Service Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Drug Consulting Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst